financetom
Business
financetom
/
Business
/
Havells India Q1 preview: Street expects strong revenue growth on low base, EBITDA margin expansion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Havells India Q1 preview: Street expects strong revenue growth on low base, EBITDA margin expansion
Jul 20, 2021 7:44 AM

Havells India will be reporting its first-quarter earnings tomorrow. The company is expected to report a strong quarter on account of a low base.

Revenue growth for Q1 is seen at 53 percent, around 350 basis point improvement in EBITDA margins at around 12.4 percent and the net profit is also seen up 180 percent.

High revenues would be on account of the low base but there could be some tempering due problems we had in month of May on account of COVID second wave. Also, gross margins could be under pressure because of higher commodity costs but a lot of other cost efficiencies will play in favour of the company, and hence EBITDA margin expansion is likely.

For more, watch the video

(Edited by : Aditi Gautam)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Super Micro Computer Stock Continues To Climb: What's Going On?
Super Micro Computer Stock Continues To Climb: What's Going On?
Feb 19, 2025
Super Micro Computer Inc ( SMCI ) shares are trading higher Wednesday on what appears to be continued momentum from last week. Investors await an update from the company regarding its delayed filings. What To Know: Super Micro’s independent auditor Ernst & Young resigned last October over governance and transparency concerns, which led to the company delaying the filing of its quarterly...
Amneal Pharmaceuticals Launching Mesalamine, Gets US FDA Approval for Lenalidomide
Amneal Pharmaceuticals Launching Mesalamine, Gets US FDA Approval for Lenalidomide
Feb 19, 2025
09:28 AM EST, 02/19/2025 (MT Newswires) -- Amneal Pharmaceuticals ( AMRX ) said Wednesday that it will launch mesalamine 800 milligram delayed-release tablets to treat moderately active ulcerative colitis in adults. The company also said it has received approval from the US Food and Drug Administration for an abbreviated new drug application for lenalidomide capsules, which are used to treat...
Trump Media, Rumble sue Brazilian supreme court justice
Trump Media, Rumble sue Brazilian supreme court justice
Feb 19, 2025
WASHINGTON/SAO PAULO (Reuters) - U.S. President Donald Trump's Trump Media & Technology Group ( DJT ) and video-sharing platform Rumble sued a Brazilian Supreme Court justice over accusations of illegal censorship on Wednesday. The case comes as the judge, Alexandre de Moraes, weighs charges brought on Tuesday alleging former President Jair Bolsonaro led a plot to overthrow Brazil's government and...
Nicknames bloom in China's tech renaissance
Nicknames bloom in China's tech renaissance
Feb 19, 2025
* Surge in Chinese tech stocks captures analysts' imagination * Catchy monikers rival 'Magnificent Seven' in the US * AI startup DeepSeek fuels buzz around technology companies By Tom Westbrook and Samuel Shen SINGAPORE/SHANGHAI, Feb 19 (Reuters) - Six Little Dragons, Seven Sisters and the Terrific Ten. These are some of the nicknames being bestowed on China's cast of home-grown...
Copyright 2023-2026 - www.financetom.com All Rights Reserved